Trends in first-line antiretroviral therapy in Asia: results from the TREAT Asia HIV observational database (Q28542731)

20 October 2023

Adeeba Kamarulzaman

Adeeba

Kamarulzaman

1 reference

Nagalingeswaran Kumarasamy

20 October 2023

object named as

Nagalingeswaran Kumarasamy

Nagalingeswaran

Kumarasamy

1 reference

Sasisopin Kiertiburanakul

20 October 2023

object named as

Sasisopin Kiertiburanakul

Sasisopin

Kiertiburanakul

1 reference

20 October 2023

Matthew Law

Matthew

Law

1 reference

20 October 2023

Romanee Chaiwarith

Romanee

Chaiwarith

1 reference

20 October 2023

Rossana Ditangco

Rossana

Ditangco

1 reference

20 October 2023

Sanjay Pujari

Sanjay

Pujari

1 reference

20 October 2023

Fujie Zhang

Fujie

Zhang

1 reference

20 October 2023

Tuti Parwati Merati

Tuti Parwati

Merati

1 reference

20 October 2023

Evy Yunihastuti

Evy

Yunihastuti

1 reference

20 October 2023

author name string

David Charles Boettiger

David Charles

Boettiger

1 reference

20 October 2023

Stephen Kerr

Stephen

Kerr

1 reference

20 October 2023

Thuy Thi Thanh Pham

Thuy Thi Thanh

Pham

1 reference

20 October 2023

Chung Ki Patrick Li

Chung Ki Patrick

1 reference

20 October 2023

Saphonn Vonthanak

Saphonn

Vonthanak

1 reference

20 October 2023

Christopher Lee

Christopher

Lee

1 reference

20 October 2023

Nguyen Van Kinh

Nguyen

Van Kinh

1 reference

20 October 2023

Wing Wai Wong

Wing Wai

Wong

1 reference

20 October 2023

Shinichi Oka

Shinichi

Oka

1 reference

20 October 2023

Oon Tek Ng

Oon Tek

1 reference

20 October 2023

Pacharee Kantipong

Pacharee

Kantipong

1 reference

20 October 2023

Mahiran Mustafa

Mahiran

Mustafa

1 reference

20 October 2023

Winai Ratanasuwan

Winai

Ratanasuwan

1 reference

20 October 2023

Annette Sohn

Annette

Sohn

1 reference

Creative Commons Attribution 4.0 International

20 October 2023

language of work or name

English

0 references

publication date

2014

0 references

0 references

0 references

0 references

e106525

0 references

start time

3 September 2014

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4153611

Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4153611

Temporal trends in the discontinuation of first-line antiretroviral therapy

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4153611

Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4153611

Increased hot flash severity and related interference in perimenopausal human immunodeficiency virus-infected women

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4153611

Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4153611

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4153611

Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4153611

A brief history of antiretroviral therapy of HIV infection: success and challenges

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4153611

Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4153611

Regional changes over time in initial virologic response rates to combination antiretroviral therapy across Europe

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4153611

Longitudinal trends in antiretroviral use in a cohort of men and women in Ontario, Canada.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4153611

Trends in antiretroviral therapy use and survival rates for a large cohort of HIV-infected children and adolescents in the United States, 1989-2001.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4153611

The TREAT Asia HIV Observational Database: baseline and retrospective data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4153611

Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4153611

British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012.

3 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106525

Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106525

Improvements in subcutaneous fat, lipid profile, and parameters of mitochondrial toxicity in patients with peripheral lipoatrophy when stavudine is switched to tenofovir (LIPOTEST study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106525

Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106525

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0106525

The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4153611

Superior virological efficacy of ritonavir-boosted protease inhibitor regimens compared to single protease inhibitor therapy.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4153611

Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial

27 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/25184314

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0106525

1 reference

ADS bibcode

2014PLoSO...9j6525B

0 references

1 reference

1 reference

1 reference